NY Insurer CEO doubles salary in concurrent attempt at making PT extinct • Posts by EIM | Evidence In Motion Skip To Content

NY Insurer CEO doubles salary in concurrent attempt at making PT extinct

April 30, 2009 • Advocacy • Larry Benz

HIP/EMBLEM a NY insurer that covers 4 million lives of government workers primarily has just reduced the global fee from $55 to $45 statewide citing that it is “in line with patterns in the industry” and that the old reimbursement rate of $55 was “well above the industry norm”.

Help me out here Mr. Anthony Watson (CEO) and show anybody any kind of data that $55 or $45 is within any norm in the industry. The only published benchmark is CMS data and an extrapolation of that data for New York and in particularly in the city where rents are $30–$40 more approximates $90 and industry trends and work comp are negotiated above CMS rates.  I promise we can show you more data of CEO’s taking reduction in compensation versus doubling their take home.

The fundamental question is how can this happen?  The conventional wisdom is “cause they can”.  This is unfortunately true if too many unwise providers accept rates that will make them go the way of Shakers.  Perhaps HIP/EMBLEM and their bloated CEO don’t remember the mass providers who finally said no to the ridiculous rates by the former ACN division of UHC.

It’s a good thing PT’s like Dr. Dimitrios are not afraid to go public and is going one step further by leading his staff to HIP offices in NYC to protest this impending 20% reductions.

Watch Dick Brennan’s TV report here.

larry@physicaltherapist.com

Larry Benz

Dr. Larry Benz, DPT, OCS, MBA, MAPP, is the Executive Chairman of Confluent Health. He is nationally recognized for his expertise in private practice physical therapy and occupational medicine. Dr. Benz’s current areas of interest include conducting research and integrating empathy, compassion, and positive psychology interventions within physical therapy. He released a book on September...

––– Related Items

––– Post a Comment

— All comments subject to approval

Your email address will not be published. Required fields are marked *

Sign up for news

Join the EIM Mailing List to receive next level updates on research, news, and educational offerings.